| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |